RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,000 | +85.2% | 26,165 | +80.6% | 0.00% | – |
| Q2 2023 | $108,000 | +103.8% | 14,489 | +83.2% | 0.00% | – |
| Q1 2023 | $53,000 | -69.2% | 7,908 | -64.7% | 0.00% | – |
| Q4 2022 | $172,000 | +719.0% | 22,409 | +1051.0% | 0.00% | – |
| Q3 2022 | $21,000 | +162.5% | 1,947 | +92.4% | 0.00% | – |
| Q2 2022 | $8,000 | -84.3% | 1,012 | -85.7% | 0.00% | – |
| Q1 2022 | $51,000 | -88.0% | 7,081 | -71.5% | 0.00% | – |
| Q4 2021 | $425,000 | +553.8% | 24,803 | +770.6% | 0.00% | – |
| Q3 2021 | $65,000 | +22.6% | 2,849 | +97.2% | 0.00% | – |
| Q2 2021 | $53,000 | – | 1,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 67,871 | $669,208 | 0.48% |
| GoalFusion Wealth Management, LLC | 20,000 | $197,200 | 0.13% |
| BALDWIN BROTHERS LLC/MA | 7,336 | $72,333 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 16,359 | $161,300 | 0.00% |